CVS Drops Zepbound + Lilly Earnings Call Recap

CVS announces major partnership with Novo Nordisk as Lilly announces Q! 2025 earnings. Dave covers it all in today's breakdown.

Join the Substack: https://substack.com/@onthepen

WAYS TO SUPPORT MY WORK ⬇️

💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS:
BPC-157 // Can’t Weight // TB4-FRAG // KPV
Sign up here and use code “OTP10” to save 10%
https://integrativepeptides.com/OTP

WHY I TRUST INTEGRATIVE PEPTIDES:
🇺🇸 Made in the USA
📋 CGMP Compliant (FDA oversight of their products)
🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA

📕 GET MY BOOK!
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
https://amzn.to/4gAXrz4

SOCIALS:
📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx
🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1
👾: https://discord.gg/ZHeUh7WV
📺: https://youtube.com/@ManOnTheMounjaro?feature=shared
❌: https://x.com/manonthepen?s=21
💻: https://www.onthepen.com

https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.